31.07.2013 • News • Dede Willams • DuPont • Q2 2013

DuPont Operating Profit Recedes by 16% in Q2

Sales of the DuPont group were virtually flat in Q2 2013, with the slight revenue setback of 1% to $9.8 billion blamed on poor pricing for the titanium dioxide business it plans to sell or spin off. Operating profit fell 16% year-on-year to $1.9 billion. Among business segments, Agriculture is credited with the best quarterly performance. For full year 2013, CEO Ellen Kullman said she expects DuPont to deliver earnings "modestly above 2012 results," thereby overcoming "steep declines" in the TiO2 market and economic headwinds in Europe. 

Interview

Fostering Innovation and Collaboration
Specialty Chemicals Distributor IMCD’s Strategy

Fostering Innovation and Collaboration

Valerie Diele-Braun, CEO of IMCD, shares her vision for sustainability, global expansions, and strategic direction in an exclusive CHEManager International interview.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Top-Feature